Birmingham, AL, United States of America

Andrew B West

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew B West

Introduction

Andrew B West is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on creating inhibitors for the LRRK2 kinase, which plays a crucial role in various disease states.

Latest Patents

Andrew B West holds a patent for "Triazolopyridazine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof." This patent includes innovative LRRK2 kinase inhibitors and outlines methods for treating diseases using these compounds. One example of his work is the compound 1-(piperidin-1-yl)-2-((3-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)thio)butan-1-one. The applications of these inhibitors include treating neurodegenerative diseases, cancer, autoimmune diseases, and leprosy.

Career Highlights

Throughout his career, Andrew has worked with esteemed organizations such as Southern Research Institute and the UAB Research Foundation. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Andrew has collaborated with notable colleagues, including Robert A Galemmo, Jr and Joseph A Maddry. These partnerships have further enriched his research endeavors and expanded the impact of his work.

Conclusion

Andrew B West's innovative contributions to the field of medicinal chemistry highlight his dedication to advancing therapeutic solutions for complex diseases. His work continues to inspire future research and development in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…